GoAI
Get started
FINDEX Inc. logo

FINDEX Inc.

3649.T

JPXHealthcareMedical - Healthcare Information Services

Open in GoAI

Latest quote

¥876

+¥6.00 · +0.69%

Aug 24, 2:47 PM JST

3649.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

FINDEX Inc., a company established in Tokyo in 1985, focuses on the creation, production, and distribution of medical technology systems across Japan. Their portfolio features Claio, a comprehensive medical imaging database management system utilized by hospitals of all sizes, and C-Note, a dedicated platform for managing patient progress notes. They also offer DocuMaker, a sophisticated document and data management solution engineered with various input tools to boost efficiency, and the GAP/GAP-screener, which is an advanced gaze analyzing perimeter. Additionally, FINDEX Inc. develops mobile applications for smartphones. Their services cater to a wide range of medical clients, including hospitals, clinics, and other healthcare institutions. The organization adopted its current name, FINDEX Inc., in November 2014, having previously operated as PSC Inc.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
JP
CEO
Teruo Aibara
Listed since
Mar 23, 2011
Employees
325

Market position

Day range

Current ¥876

52-week range

Current ¥876

Open
¥871
Previous close
¥870
Volume
40.9K
0.45× average
Average volume
90.82K
Average daily volume
Market cap
21.38B JPY
Beta
0.34
Market reference 1
50-day average
¥835.42
+4.86% above average
200-day average
¥854.61
+2.50% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
21.12B JPY
P/E (TTM)
18.99×
P/B (TTM)
3.79×
P/S (TTM)
3.49×
EV / EBITDA
10.1×
Earnings yield
5.51%
Free cash flow yield
7.09%
Dividend yield
3.08%

Profitability & efficiency

Gross margin
65.54%
Operating margin
28.12%
Net margin
18.47%
Return on equity
23.10%
Return on assets
18.46%
Return on invested capital
22.19%

Financial health

Debt / equity
0×
Current ratio
3.65×
Altman Z-score
13.97
Piotroski F-score
4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends70%49%29%8%Gross margin, FY2021: 51.45%Gross margin, FY2022: 59.96%Gross margin, FY2023: 64.13%Gross margin, FY2024: 60.83%Gross margin, FY2025: 65.22%Operating margin, FY2021: 18.52%Operating margin, FY2022: 22.65%Operating margin, FY2023: 28.83%Operating margin, FY2024: 26.11%Operating margin, FY2025: 29.30%Net margin, FY2021: 12.80%Net margin, FY2022: 15.92%Net margin, FY2023: 20.40%Net margin, FY2024: 19.90%Net margin, FY2025: 20.57%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 51.45%. Gross margin FY2022 59.96%. Gross margin FY2023 64.13%. Gross margin FY2024 60.83%. Gross margin FY2025 65.22%. Operating margin FY2021 18.52%. Operating margin FY2022 22.65%. Operating margin FY2023 28.83%. Operating margin FY2024 26.11%. Operating margin FY2025 29.30%. Net margin FY2021 12.80%. Net margin FY2022 15.92%. Net margin FY2023 20.40%. Net margin FY2024 19.90%. Net margin FY2025 20.57%.

Income trends

Revenue

6.11B JPY+4.60%

Operating income

1.79B JPY+17.35%

Net income

1.26B JPY+8.14%
Income trends across reported periods6.66B JPY4.47B JPY2.28B JPY88.63M JPYRevenue, FY2021: 4.97B JPYRevenue, FY2022: 4.54B JPYRevenue, FY2023: 5.19B JPYRevenue, FY2024: 5.84B JPYRevenue, FY2025: 6.11B JPYOperating income, FY2021: 920.36M JPYOperating income, FY2022: 1.03B JPYOperating income, FY2023: 1.5B JPYOperating income, FY2024: 1.53B JPYOperating income, FY2025: 1.79B JPYNet income, FY2021: 636.03M JPYNet income, FY2022: 722.78M JPYNet income, FY2023: 1.06B JPYNet income, FY2024: 1.16B JPYNet income, FY2025: 1.26B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 4.97B JPY. Revenue FY2022 4.54B JPY. Revenue FY2023 5.19B JPY. Revenue FY2024 5.84B JPY. Revenue FY2025 6.11B JPY. Operating income FY2021 920.36M JPY. Operating income FY2022 1.03B JPY. Operating income FY2023 1.5B JPY. Operating income FY2024 1.53B JPY. Operating income FY2025 1.79B JPY. Net income FY2021 636.03M JPY. Net income FY2022 722.78M JPY. Net income FY2023 1.06B JPY. Net income FY2024 1.16B JPY. Net income FY2025 1.26B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue6.11B JPY5.84B JPY5.19B JPY4.54B JPY4.97B JPY
Cost of goods sold2.12B JPY2.29B JPY1.86B JPY1.82B JPY2.41B JPY
Gross profit3.98B JPY3.55B JPY3.33B JPY2.72B JPY2.56B JPY
Research and development—40.43M JPY52.9M JPY39.02M JPY27.07M JPY
Selling, general, and administrative2.19B JPY1.99B JPY1.78B JPY1.66B JPY1.61B JPY
Operating expenses2.19B JPY2.03B JPY1.83B JPY1.69B JPY1.64B JPY
Interest income48.38M JPY3.73M JPY72K JPY47K JPY22K JPY
Interest expense———448K JPY2K JPY
Depreciation and amortization307.31M JPY290.73M JPY257.75M JPY254.96M JPY308.3M JPY
Operating income1.79B JPY1.53B JPY1.5B JPY1.03B JPY920.36M JPY
Net income1.26B JPY1.16B JPY1.06B JPY722.78M JPY636.03M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-0.11

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates24.9215.967-1.96Q4 '24Q1 '25Q2 '25Q3 '25Q3 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 13, 2024: actual 5.08, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 11, 2025: actual 12.89, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 14, 2025: actual 22.53, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 12, 2025: actual 4.27, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual 6.8, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 12, 2026: actual 16.35, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 14, 2026: actual 23.07, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 13, 2026: actual -0.108, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates2.07B1.72B1.36B1.01BQ1 '25MissQ2 '25BeatQ3 '25MissQ3 '25BeatQ1 '26MissQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 11, 2025: actual 1.53B JPY, estimate 1.6B JPY, surprise -4.30%, Miss. Q2 2025, reported May 14, 2025: actual 1.95B JPY, estimate 1.09B JPY, surprise +79.04%, Beat. Q3 2025, reported Aug 12, 2025: actual 1.17B JPY, estimate 1.84B JPY, surprise -36.19%, Miss. Q3 2025, reported Sep 30, 2025: actual 1.25B JPY, estimate 1.19B JPY, surprise +5.17%, Beat. Q1 2026, reported Feb 12, 2026: actual 1.74B JPY, estimate 1.77B JPY, surprise -2.09%, Miss. Q2 2026, reported May 14, 2026: actual 1.99B JPY, estimate 1.67B JPY, surprise +19.10%, Beat. Q3 2026, reported Aug 13, 2026: actual 1.16B JPY, estimate 1.19B JPY, surprise -2.94%, Miss. Q4 2026, reported Nov 18, 2026: actual —, estimate 1.21B JPY, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥22.00

2025 complete year+175.0% since 2021

2026 partial: ¥13.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Dec 29, 2026

¥14.00

Semi-Annual

Record Dec 31, 2026 · Payment Dec 29, 2026

Dividend

Ex-dividend Jun 29, 2026

¥13.00

Semi-Annual

Record Jun 30, 2026 · Payment Sep 11, 2026

Dividend

Ex-dividend Dec 29, 2025

¥14.00

Semi-Annual

Record Dec 31, 2025 · Payment Mar 27, 2026

Dividend

Ex-dividend Jun 27, 2025

¥8.00

Semi-Annual

Record Jun 30, 2025 · Payment Sep 12, 2025

Dividend

Ex-dividend Dec 27, 2024

¥8.00

Semi-Annual

Record Dec 31, 2024 · Payment Mar 28, 2025

Dividend

Ex-dividend Jun 27, 2024

¥7.00

Semi-Annual

Record Jun 30, 2024 · Payment Sep 12, 2024

3649.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,989

-0.31%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,817

+0.92%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,030

+0.54%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,280

+0.70%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,405

+0.75%

ETFs holding 3649.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core TOPIX ETF logoiShares Core TOPIX ETF1475.T
Market value
33.15M
Weight
0.00%
AUM
2.89T JPY
Expense ratio
0.05%
Price / 1D
¥418.4+0.10%
State Street SPDR Portfolio Developed World ex-US ETF logoState Street SPDR Portfolio Developed World ex-US ETFSPDW
Market value
1.05M
Weight
0.00%
AUM
41.92B USD
Expense ratio
0.03%
Price / 1D
$52.02+0.79%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
131.7K
Weight
0.00%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%
Dimensional - International Core Equity 2 ETF logoDimensional - International Core Equity 2 ETFDFIC
Market value
105.58K
Weight
0.00%
AUM
15.43B USD
Expense ratio
0.22%
Price / 1D
$39.405+0.83%
Dimensional World ex U.S. Core Equity 2 ETF logoDimensional World ex U.S. Core Equity 2 ETFDFAX
Market value
61.68K
Weight
0.00%
AUM
12.57B USD
Expense ratio
0.28%
Price / 1D
$38.16+0.82%
Dimensional - International Core Equity Market ETF logoDimensional - International Core Equity Market ETFDFAI
Market value
37.23K
Weight
0.00%
AUM
18.23B USD
Expense ratio
0.18%
Price / 1D
$43.35+0.81%
Avantis International Equity ETF logoAvantis International Equity ETFAVDE
Market value
16.57K
Weight
—
AUM
19.1B USD
Expense ratio
0.23%
Price / 1D
$94.26+0.87%
Avantis International Small Cap Equity ETF logoAvantis International Small Cap Equity ETFAVDS
Market value
1.66K
Weight
—
AUM
340.61M USD
Expense ratio
0.30%
Price / 1D
$80.49+0.93%

Continue in GoAI

Research 3649.T

research.disclaimer